Tudor Investment Corp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-619,565
Closed -$110M 1524
2020
Q1
$110M Sell
619,565
-525
-0.1% -$98.9K 9.83% 1
2019
Q4
$119M Buy
620,090
+58,590
+10% +$10.6M 5.32% 1
2019
Q3
$94.5M Buy
561,500
+297,584
+113% +$48.5M 3.24% 4
2019
Q2
$44.2M Buy
263,916
+220,423
+507% +$30.5M 1.26% 10
2019
Q1
$6.37M Buy
43,493
+3,721
+9% +$539K 0.26% 64
2018
Q4
$5.32M Buy
39,772
+10,796
+37% +$1.77M 0.11% 50
2018
Q3
$5.52M Buy
28,976
+4,426
+18% +$813K 0.14% 90
2018
Q2
$4.09M Buy
+24,550
New +$3.94M 0.14% 107
2018
Q1
Sell
-36,855
Closed -$6.03M 1360
2017
Q4
$6.03M Buy
36,855
+28,930
+365% +$5.19M 0.15% 22
2017
Q3
$1.62M Buy
+7,925
New +$1.84M 0.04% 258
2017
Q2
Sell
-4,591
Closed -$1.1M 1518
2017
Q1
$1.1M Sell
4,591
-26,809
-85% -$6.24M 0.03% 346
2016
Q4
$6.59M Buy
31,400
+3,972
+14% +$823K 0.17% 85
2016
Q3
$6.32M Sell
27,428
-7,514
-22% -$1.84M 0.15% 97
2016
Q2
$8.07M Sell
34,942
-65,547
-65% -$15.1M 0.17% 68
2016
Q1
$26.9M Buy
100,489
+49,632
+98% +$14.2M 0.69% 21
2015
Q4
$15.9M Buy
50,857
+39,540
+349% +$11.8M 0.45% 39
2015
Q3
$3.08M Buy
11,317
+5,380
+91% +$1.65M 0.1% 140
2015
Q2
$1.8M Buy
5,937
+3,737
+170% +$1.11M 0.05% 227
2015
Q1
$655K Sell
2,200
-500
-19% -$143K 0.02% 590
2014
Q4
$695K Sell
2,700
-98,493
-97% -$24.6M 0.02% 544
2014
Q3
$24.4M Sell
101,193
-307
-0.3% -$68.7K 0.88% 11
2014
Q2
$22.6M Buy
101,500
+48,300
+91% +$10M 0.87% 14
2014
Q1
$11M Buy
53,200
+51,500
+3,029% +$10.2M 0.46% 52
2013
Q4
$286K Buy
1,700
+300
+21% +$46.9K 0.01% 912
2013
Q3
$202K Sell
1,400
-101,800
-99% -$13.6M 0.01% 738
2013
Q2
$13M Buy
+103,200
New +$11.7M 0.98% 21

Other funds holding AGN

Tudor Investment Corp's AGN Position: Q2 2020 in Review

Tudor Investment Corp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 619,565 shares — an estimated $110M sold.

Tudor Investment Corp first reported a position in AGN in Q2 2013 and held it in 26 quarters. The position peaked at $119M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tudor Investment Corp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 619,565 Allergan plc shares in Q2 2020, an estimated $110M.
  • Tudor Investment Corp first reported a position in Allergan plc in Q2 2013 and held it in 26 quarters.
  • Tudor Investment Corp's Allergan plc position peaked at $119M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tudor Investment Corp's 13F filing for Q2 2020, filed 14 Aug 2020.